Shares of Evolus Inc. (Nasdaq: EOLS) soared 14% in after-hours trading after the Newport Beach-based aesthetics company reported its first-ever operating profit, two quarters ahead of schedule.
The shares climbed to $14.20 after closing the day at $12.42 and a $788 million market cap.
Second-quarter sales increased 36% to $66.9 million, above the $65.8 million expected by analysts. The company boosted its full-year revenue to $260 million to $270 million, up $5 million from a prior forecast and above the analyst estimate of $263 million.
The company also said it had non-GAAP operating income of $1.1 million when analysts projected a $2.6 million loss.
“We are thrilled to have achieved quarterly profitability for the first time, driven by record revenue, demonstrating our continued strong execution and unwavering commitment to building a leadership position in the performance beauty industry,” Chief Executive David Moatazedi said in a statement.
